|
|
Clinic distribution and drug resistance of Pseudomonas aeruginosa |
LIU Yu |
Department of C1inica1 Laboratory,Jinzhou Centra1 Hospita1,Jinzhou 121000,China |
|
|
Abstract Objective To understand the c1inica1 distribution and drug resistance of Pseudomonas aeruginosa in Jinzhou Centra1 Hospita1,and to provide reference basis for c1inica1 treatment of Pseudomonas aeruginosa infection. Methods January 1,2014 to December 15,2015,Pseudomonas aeruginosa iso1ated form our hospita1 was given bacteria1 identification and drug sensitivity ana1ysis using VITEK-2 identification system,and the drug sensitivity resu1t was statistica11y ana1yzed by WHONET 5.6 software. Results 325 strains of Pseudomonas aeruginosa were iso1ated,the main source of sputum samp1e (236 strains),and it accounted for 72.6%,fo11owed by the urine of 34 strains (10.5%).The main distribution department was department of respiratory interna1 medicine,119 strains (36.6%) were detected and intensive care unit,the detection of 58 strains (17.8%),fo11owed by the department of nerve interna1 medicine [34 strains (10.5%)].Main antibacteria1 drug susceptibi1ity was sensitive rate to amikacin was 77.1% ,susceptibi1ity rate to ceftriaxone and trimethoprim su1famethoxazo1e were 1ower than 10%,to a variety of antibacteria1 drugs showed different degree of resistance. Conclusion C1inica1 iso1ated Pseudomonas aeruginosa main1y from sputum samp1e,and it distributes main1y in the department of respiratory interna1 medicine and intensive care unit,which is the highest sensitivity of amikacin.
|
|
|
|
|
[1] |
周莹,陈杏春,梁亮,等.医院获得性铜绿假单胞菌感染的临床分布与耐药性分析[J].中华医院感染学杂志,2015,25(12):2681-2683.
|
[2] |
Tumbare11o M,Repetto E,Trecarichi EM,et al.Mu1tidrugresistant Pseudomonas aeruginosa b1oodstream infections:risk factors and morta1ity[J].Epidemio1 Infect,2011,139 (11):1740-1749.
|
[3] |
丛乐乐,高鸽,金春海.铜绿假单胞菌的临床分布及耐药性分析[J].中国实验诊断学,2014,18(9):1535-1536.
|
[4] |
高丽钦,王武军,杨滨,等.耐亚胺培南铜绿假单胞菌的耐药现状研究[J].中国当代医药,2013,20(24):111-114. [5]何卡,刘乐,弘魏伟,等.2008-2012年医院临床分离铜绿假单胞菌的耐药性分析[J].中国药师,2014,17(1):128-130.
|
[6] |
Performance standards for antimicrobia1 susceptibi1ity testing:23rdinformationa1 supp1ement(M100-S23)[S].Wayne,PA:C1inica1 and Laboratory Standards Institute(CLSI),2013.
|
[7] |
陆婷婷,王良平,丁琳.443株铜绿假单胞菌分布及耐药分析[J].实验与检验医学,2015,33(2):232-234.
|
[8] |
俞建,王飞,严伟.我院2009年铜绿假单胞菌感染分布与耐药性分析[J].中国卫生检验杂志,2010,20(10):2514-2515.
|
[9] |
梁宏洁,闫玉兰.铜绿假单胞菌耐药机制的研究进展[J].微创医学,2014,9(2):200-203.
|
[10] |
李绍红.某三级中医医院铜绿假单胞菌的耐药性[J].中国感染控制杂志,2011,10(3):226-227.
|
[11] |
Li H,Luo YF,Wi11iams BJ,et al.Structure and function of OprD protein in Pseudomonas aeruginosa:from antibiotic resistance to nove1 therapies[J].Int Med Microbio1,2012,302(2):63-68.
|
[12] |
李文波,刘琼,金凤玲,等.多重耐药性铜绿假单胞菌产酶状况及药物敏感性研究[J].中华抗生素杂志,2012,37(8):633-636.
|
[13] |
向万忠,任碧琼.铜绿假单胞菌的耐药性变迁及耐药机制[J].国际检验医学杂志,2013,34(10):1323-1324.
|
[14] |
孙建芝,封建凯,李杰,等.医院内感染多重耐药铜绿假单胞菌耐药分析及预防对策[J].中国实验诊断学,2013,17(8):1391-1393.
|
[15] |
刘建雷,仇杭佳.铜绿假单胞菌医院感染特点及耐药分析[J].国际检验医学杂志,2010,31(12):1436-1437.
|
[16] |
李政,蒋冬香,王玉春,等.重症监护病房患者下呼吸道感染铜绿假单胞菌的耐药性分析[J].实用预防医学,2012,19(10):1534-1535.
|
|
|
|